Back to search

Article

Persistent Cytotoxic Immune Signaling in Anti-VEGF–Treated Neovascular Age-Related Macular Degeneration

2026-04-10

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Anti-vascular endothelial growth factor (anti-VEGF) therapy is the standard of care for neovascular age-related macular degeneration (AMD), yet many patients exhibit persistent retinal degeneration, fibrosis, and incomplete therapeutic response. The molecular pathways underlying this incomplete response remain poorly understood. We sought to identify VEGF-independent signaling...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
13893095-caae-511c-9276-c0274a9beff7
DOI
10.64898/2026.04.06.26350115
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Persistent Cytotoxic Immune Signaling in Anti-VEGF–Treated Neovascular Age-Related Macular DegenerationDOI 10.64898/2026.04.06.26350115
Select a neighboring publication to make it the new centre.